Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004642
What this trial is testing

Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease

Who this might be right for
Cytomegalovirus Infections
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Testing effectiveness (Phase 2)UnknownNCT04714060
What this trial is testing

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 44
Testing effectiveness (Phase 2)Study completedNCT00148824
What this trial is testing

Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults.

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 212
Testing effectiveness (Phase 2)Study completedNCT01651715
What this trial is testing

Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections

Who this might be right for
Common Cold
Theranor s.p.r.l 232
Large-scale testing (Phase 3)Study completedNCT05110261
What this trial is testing

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Who this might be right for
Lower Respiratory Tract Infection
AstraZeneca 800
Not applicableStudy completedNCT01317784
What this trial is testing

Behavioral Science Aspects of Rapid Test Acceptance

Who this might be right for
HIVHepatitis CHepatitis B+1 more
California State University, Long Beach 1,200
Testing effectiveness (Phase 2)WithdrawnNCT05393999
What this trial is testing

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations

Who this might be right for
SARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory DiseaseMyeloma+4 more
Imperial College Healthcare NHS Trust
Post-approval studies (Phase 4)Study completedNCT01285050
What this trial is testing

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 20
Not applicableUnknownNCT04469647
What this trial is testing

COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH

Who this might be right for
COVID 19
Johns Hopkins Aramco Healthcare 1,200
Early research (Phase 1)Study completedNCT03205917
What this trial is testing

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 29
Post-approval studies (Phase 4)Study completedNCT06020118
What this trial is testing

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

Who this might be right for
InfluenzaCOVID-19
Duke University 455
Not applicableStudy completedNCT04562285
What this trial is testing

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Who this might be right for
Covid19
Henry Ford Health System 829
Testing effectiveness (Phase 2)WithdrawnNCT03619278
What this trial is testing

Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection

Who this might be right for
HIV Infections
Judit Pich
Not applicableUnknownNCT04515225
What this trial is testing

COVID-19 Prevalence in HIV-infected Patients

Who this might be right for
HIV Infections
University Hospital, Strasbourg, France 500
Large-scale testing (Phase 3)Study completedNCT04625725
What this trial is testing

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Who this might be right for
COVID-19
AstraZeneca 5,197
Early research (Phase 1)WithdrawnNCT05157997
What this trial is testing

Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail

Who this might be right for
COVID-19Organ Transplant
Northwell Health
Large-scale testing (Phase 3)Study completedNCT00303316
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi 458
Not applicableStudy completedNCT00395278
What this trial is testing

Development of Serologic Assays for Human Herpes Virus-8

Who this might be right for
Kaposi SarcomaHIV Infection
National Institutes of Health Clinical Center (CC) 394
Large-scale testing (Phase 3)Study completedNCT00534833
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 362
Next Page